Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$37.4B | 5.7 | $132.4 61.2% undervalued | (9.2%) | $19.7B | $1,550.0M | 0.6% | 7.9% | 41.7% | 10.9% | 17.4% | |
$38.0B | 7.7 | $144.6 38.8% overvalued | 3.5% | $2,746.6M | $1,078.5M | 16.2% | 39.3% | 74.5% | 38.8% | 1.3% | |
$11.4B | 8.2 | $23.2 62.2% overvalued | 119.9% | $550.2M | $238.8M | 17.5% | 43.4% | 90.2% | 69.3% | 1.3% | |
$8,792.1M | 6.3 | $55.2 45.7% overvalued | 22.6% | $1,150.3M | ($162.0M) | 18.5% | (14.1%) | 58.4% | 4.8% | 5.1% | |
$6,040.3M | 6.0 | $12.5 12.9% overvalued | 33.2% | $2,463.7M | $186.4M | 11.4% | 7.6% | 19.2% | 2.5% | 83.1% | |
$2,832.8M | 5.7 | $2,568.9 10,776.0% undervalued | 17.3% | $1,736.4M | $109.3M | 4.7% | 6.3% | 10.2% | 0.0% | 0.0% | |
$1,778.8M | 6.6 | $29.6 39.7% undervalued | (41.6%) | $1,167.2M | $173.7M | 7.2% | 14.9% | 21.7% | 20.1% | 4.6% | |
$1,747.5M | 5.7 | $53.3 187.5% undervalued | (11.2%) | $1,181.3M | $368.5M | (10.2%) | 31.2% | 66.5% | (2.6%) | 9.4% | |
$1,721.0M | 5.6 | $6.2 42.2% overvalued | (40.9%) | $385.1M | $73.4M | 8.7% | 19.1% | 53.1% | 0.8% | 2.9% | |
$1,694.3M | 6.4 | $7.0 55.6% undervalued | (31.8%) | $792.3M | $113.5M | 5.6% | 14.3% | 89.8% | 10.1% | 7.8% | |
$1,516.9M | 5.6 | $40.7 23.7% undervalued | 19.9% | $1,112.2M | $139.4M | (3.0%) | 12.5% | 42.6% | (0.7%) | 29.9% |
As of today, GE HealthCare Technologies Inc. has a stock rating of 6 (out of 10), which is considered Good.
As of today, GE HealthCare Technologies Inc. has a Good stock rating, which is 61.2% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.